首页> 美国卫生研究院文献>Data in Brief >Data on the 21-Hydroxylase deficient CAH patients and theidentification of knownovel mutations in CYP21A2 gene
【2h】

Data on the 21-Hydroxylase deficient CAH patients and theidentification of knownovel mutations in CYP21A2 gene

机译:缺乏21-羟化酶的CAH患者和CYP21A2基因已知/新颖突变的鉴定

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This article presents the dataset regarding spectrum of mutations in 21-Hydroxylase deficient CAH patients as described in “The spectrum of CYP21A2 mutations in Congenital Adrenal Hyperplasia in an Indian cohort” (R. Khajuria, R. Walia, A. Bhansali, R. Prasad, 2017) . This dataset features about the CAH patients in the cohort, their classification into subtypes and finally screening the exon–intron boundaries of 21-Hydroxylase gene (CYP21A2) to detect common mutations, novel mutations along polymorphisms in the CYP21A2 gene. The specified large set of primers and the parameters for the mutation detection allow the identification and molecular characterization of CYP21A2 gene in the CAH patients.
机译:本文介绍了有关21-羟化酶缺陷型CAH患者突变谱的数据集,如“印度队列中先天性肾上腺增生的CYP21A2突变谱”中所述(R. Khajuria,R。Walia,A。Bhansali,R。Prasad ,2017)。该数据集的特征在于该队列中的CAH患者,将其分类为亚型,并最终筛选21-羟化酶基因(CYP21A2)的外显子-内含子边界,以检测常见突变,CYP21A2基因多态性的新突变。特定的大型引物集和用于突变检测的参数允许对CAH患者中的CYP21A2基因进行鉴定和分子表征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号